These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 2572250

  • 21. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK.
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [Abstract] [Full Text] [Related]

  • 22. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K, Handa S, Ogawa S, Nakamura Y, Kawamura Y.
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract] [Full Text] [Related]

  • 23. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM.
    Br J Clin Pharmacol; 1989 Nov; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [Abstract] [Full Text] [Related]

  • 24. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG, Larouchi L, Doat P, Grenet B, Fauvel JM, Bounhoure JP.
    Presse Med; 1989 Apr 01; 18(13):667-70. PubMed ID: 2566161
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
    Molajo AO, Bennett DH.
    Br Heart J; 1985 Jul 01; 54(1):17-21. PubMed ID: 2861834
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B, Verma SP, Sharma SK, Frais MA, Reynolds G, Taylor SH.
    J Cardiovasc Pharmacol; 1989 Jan 01; 13(1):155-61. PubMed ID: 2468927
    [Abstract] [Full Text] [Related]

  • 29. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
    Maack C, Böhm M, Vlaskin L, Dabew E, Lorenz K, Schäfers HJ, Lohse MJ, Engelhardt S.
    Circulation; 2003 Jul 22; 108(3):348-53. PubMed ID: 12847069
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM, Decoster PM, Buy JJ, Rousseau MF, Brasseur LA.
    Am J Cardiol; 1984 Feb 01; 53(4):439-43. PubMed ID: 6141726
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG, Dametto E, Maragno I, Razzolini R, Chinellato P, Santostasi G, Dalla Volta S.
    Cardiologia; 1996 Apr 01; 41(4):349-59. PubMed ID: 8674104
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.